Patent · US Active

Advantageous hydrogel composition

US8246993B2 · kind B2 · utility

0Cited by

4References

6Claims

0Family size

Assignee

CYTOGEL PHARMA, LLC · US

Inventors

Daqing Wu · Suwanee, US
Chih-Chang Chu · Ithaca, US
Joseph Carozza · Southport, US

Key dates

Filing date	Jun 9, 2005
Grant date	Aug 21, 2012
Priority date	—
Expiry date	Jul 28, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

New hydrogel, including a hydrogel containing cationic BSA is included in a vaccine to stimulate the immune system to increase the potency of the vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.